CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive with poor prognosis. Long non-coding RNAs (lncRNAs), a group of non-coding RNAs, play important roles in the progression of PDAC. This study aimed to investigate the potential involvement of lncRNA CCAT2 in PDAC tumorig...

Full description

Bibliographic Details
Main Authors:	Yi Cai, Xiaomei Li, Peng Shen, Dong Zhang
Format:	Article
Language:	English
Published:	BMC 2018-01-01
Series:	Biological Research
Subjects:	PDAC lncRNA CCAT2 KRAS MAPK signaling
Online Access:	http://link.springer.com/article/10.1186/s40659-017-0149-0

Similar Items

Upregulation of long noncoding RNA CCAT1-L promotes epithelial–mesenchymal transition in gastric adenocarcinoma
by: Fang H, et al.
Published: (2018-09-01)

LncRNA CCAT1 downregulation increases the radiosensitivity of non‐small cell lung cancer cells
by: Zhao Wang
Published: (2021-08-01)

Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells
by: Chun Yang, et al.
Published: (2019-04-01)

NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma
by: Tanya Schild, et al.
Published: (2021-06-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

The lncRNA CCAT2 Rs6983267 G Variant Contributes to Increased Sepsis Susceptibility in a Southern Chinese Population
by: Wu Z, et al.
Published: (2021-08-01)

Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics
by: Fan Jia, et al.
Published: (2021-08-01)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
by: Liping Shan, et al.
Published: (2020-09-01)

Long Noncoding RNA CCAT1 Functions as a Competing Endogenous RNA to Upregulate ITGA9 by Sponging MiR-296-3p in Melanoma
by: Fan J, et al.
Published: (2020-06-01)

lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
by: Ding J, et al.
Published: (2020-02-01)

The Reciprocal Interaction Between LncRNA CCAT1 and miR-375-3p Contribute to the Downregulation of IRF5 Gene Expression by Solasonine in HepG2 Human Hepatocellular Carcinoma Cells
by: Zheng Liu, et al.
Published: (2019-10-01)

The functions and oncogenic roles of CCAT1 in human cancer
by: Zheng Liu, et al.
Published: (2019-07-01)

MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS
by: Fei Xie, et al.
Published: (2019-11-01)

A Diagnostic Panel for Acquired Immune-Mediated Polyneuropathies Based on the Expression of lncRNAs
by: Bashdar Mahmud Hussen, et al.
Published: (2021-02-01)

LncRNA CCAT1 Promotes Colorectal Cancer Tumorigenesis Via A miR-181b-5p/TUSC3 Axis
by: Chen S, et al.
Published: (2019-11-01)

lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer
by: Jana-Aletta Thiele, et al.
Published: (2018-09-01)

Antitumor effects of iridomyrmecin in HeLa cervical cancer cells are mediated via apoptosis induction, loss of mitochondrial membrane potential, cell cycle arrest and down-regulation of PI3K/Akt and up-regulation of lncRNA CCAT2 expression
by: Li Lin, et al.
Published: (2016-10-01)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

Tumor-Linked Macrophages Promote HCC Development by Mediating the CCAT1/Let-7b/HMGA2 Signaling Pathway
by: Deng L, et al.
Published: (2020-12-01)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
by: Ruining Gong, et al.
Published: (2020-03-01)

Long non-coding RNA BCYRN1 exerts an oncogenic role in colorectal cancer by regulating the miR-204-3p/KRAS axis
by: Liu Yang, et al.
Published: (2020-09-01)

Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer
by: Yan Sun, et al.
Published: (2018-07-01)

CRNDE: an oncogenic long non-coding RNA in cancers
by: Ya Lu, et al.
Published: (2020-05-01)

LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer
by: Bin Song, et al.
Published: (2019-04-01)

Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
by: Liye Wang, et al.
Published: (2020-03-01)

LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity
by: Agnes Dorn, et al.
Published: (2020-05-01)

lncRNA CCAT1 promotes cell proliferation, migration, and invasion by down-regulation of miR-143 in FTC-133 thyroid carcinoma cell line
by: Tianzheng Yang, et al.
Published: (2018-05-01)

High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis
by: Chengming Tian, et al.
Published: (2021-06-01)

Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis
by: Jing Wang, et al.
Published: (2021-01-01)

Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research
by: Sibylle Baechmann, et al.
Published: (2017-05-01)

Long non‐coding RNA CCAT1 sponges miR‐490 to enhance cell proliferation and migration of non‐small cell lung cancer
by: Jingluan Wang, et al.
Published: (2021-02-01)

Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor
by: Francesca Ricciardiello, et al.
Published: (2021-02-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

PKM2 is not required for pancreatic ductal adenocarcinoma
by: Alissandra L Hillis, et al.
Published: (2018-10-01)

Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
by: Tianjiao Li, et al.
Published: (2019-09-01)

Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
by: Hoyer, Kaja
Published: (2021)

High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma
by: Dong-jin Wu, et al.
Published: (2018-10-01)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
by: Caixiang Zhang, et al.

Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
by: Julie Dardare, et al.
Published: (2021-07-01)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
by: Vikrant Rai, et al.
Published: (2020-11-01)